Skip to content

Zara Abbas, DO

NPI 1154858025ActiveIndividual· Internal Medicine, Critical Care Medicine· New York, NY

Internal Medicine, Critical Care Medicine (DO) in New York, New York, licensed in NY, with an NPI issued in May 2017. Part D covered 48 prescriptions written in 2024, 33% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 4 companies reporting payments in 2025, $201.52 in all, mostly food and beverage.

Overview

NPI1154858025
StatusActive
Entity typeIndividual
CredentialDO
Sole proprietorYes
NPI issuedMay 22, 2017
Last updated in NPPESOct 17, 2023
Certified by providerOct 17, 2023

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)48 · 66 30-day fills
Patients20
Total drug cost$4,836
Generic share33% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$201.52 · 8 payments from 4 companies
  • 2024$72.79 · 3 payments from 2 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$201.52 · 8 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Critical Care Medicine providers in New York

All Internal Medicine, Critical Care Medicine providers in New York →